SARS News and Research

RSS

Three vaccine doses are crucial to achieve effective protection against omicron

mRNA vaccines are highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. But three doses are needed to achieve a similar level of protection against omicron that two doses provide against the delta and alpha variants, finds a large US study published by The BMJ today.

10 Mar 2022

Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

Long-lasting immune activity in the airways might be the cause of persistent breathlessness following COVID-19.

10 Mar 2022

Tannic acid plays a role in inhibiting three key molecular pathways involved in SARS-CoV-2 infection

Professor Charles Ramassamy and his postdoctoral researcher Mohamed Haddad at Institut national de la recherche scientifique, in collaboration with scientists from Université de Montréal, McGill University, and Université du Québec à Montréal, believe that tannic acid plays a role in inhibiting three important molecular pathways involved in the SARS-CoV-2 infection.

10 Mar 2022

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Researchers demonstrated the anti-spike antibody response to SARS-CoV-2 infection and further estimated the acute SARS-CoV-2 infection-induced Ab activity against recently emerged variants like Omicron.

10 Mar 2022

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

In a new study, researchers presented the origins and evolution of the SARS-CoV-2 lineage B.1.1.7 in the United Kingdom.

10 Mar 2022

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

LMU scientists have investigated how most people's immune defenses are able to curb the coronavirus so effectively that pneumonia does not occur.

10 Mar 2022

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

New research discusses the role of mutations in the receptor-binding domain of the spike protein in the generation of antibody resistance and loss of vaccine efficacy.

10 Mar 2022

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

A recent study simulated the superspreading dynamics of COVID-19.

10 Mar 2022

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Researchers explored strategies to develop an mRNA-based COVID-19 vaccine that could elicit safer and wider protection against SARS-CoV-2 variants of concern.

10 Mar 2022

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

New research describes a novel approach whereby SARS-2 antigens were analyzed for conserved sites that may be targeted by broadly neutralizing antibodies that will confer immunity to other Sarbecoviruses.

10 Mar 2022

Quantification of hydrophobic interactions encoded by FP1 sequences of SARS-CoV-2 and MERS-CoV by single-molecule force measurements

Researchers quantified hydrophobic interactions encoded by fusion peptide 1 sequences of SARS-CoV-2 and MERS-CoV using single-molecule force measurements.

10 Mar 2022

How does COVID-19 affect arrythmia?

Researchers have been investigating the reports of cardiac damage in COVID-19 patients, and trying to determine if autoimmune effects could play a role.

10 Mar 2022

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Researchers isolated a large panel of broadly neutralizing antibodies from COVID-19 recovered-vaccinated donors.

10 Mar 2022

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

A new study has evaluated the association of BZD use with the clinical outcomes of SARS-CoV-2 positive patients.

10 Mar 2022

The trajectory of B-cell immunity six months after mRNA vaccination

Researchers assess SARS-CoV-2 antibodies in individuals vaccinated with a mRNA COVID-19 vaccine six months after receiving their second dose.

10 Mar 2022

Long COVID symptoms in families a year after SARS-CoV-2 infection or household exposure

A new study has analyzed symptoms up to one year of post-acute COVID-19 infection.

10 Mar 2022

Cedars-Sinai scientists identify potential new therapy for COVID-19

Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.

9 Mar 2022

New antimicrobial technology for air filters can kill bacteria, fungi and viruses in seconds

Researchers at the University of Birmingham working in partnership with firms NitroPep Ltd and Pullman AC have developed new antimicrobial technology for air filters which can in seconds kill bacteria, fungi and viruses including SARS-CoV-2 - providing a potential solution to prevent the spread of airborne infections.

9 Mar 2022

Causal links between severe COVID-19 and blood proteins identified via proteome-wide Mendelian randomization in new study

A recent study was based on Mendelian randomization analyses conducted between high levels of numerous blood proteins and COVID-19.

9 Mar 2022

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

A new study used glycoprotein profiling technology platform that couples high-resolution LC-MS for glycoprotein analysis in regards to COVID-19.

9 Mar 2022

SARS News and Research

Three vaccine doses are crucial to achieve effective protection against omicron

Long-lasting immune activity in the airways may be the cause of persistent post-COVID-19 breathlessness

Tannic acid plays a role in inhibiting three key molecular pathways involved in SARS-CoV-2 infection

Natural SARS-CoV-2 infection-induced anti-spike antibody responses

Origins and evolutions of SARS-CoV-2 Alpha variant in the UK

LMU scientists find specific immunological signature that can prevent SARS-CoV-2 virus spread

Cross-species infectivity of SARS-CoV-2 variants correlated with prevalence

Individual-based model describing the transmission and spread of SARS-CoV-2 in the Belgian population

Study finds chimeric mRNA induces potent and broadly acting neutralizing antibodies against SARS-CoV-2 variants

Engineered SARS-CoV-2 immunogens elicit broadly neutralizing antibodies

Quantification of hydrophobic interactions encoded by FP1 sequences of SARS-CoV-2 and MERS-CoV by single-molecule force measurements

How does COVID-19 affect arrythmia?

Study isolated largest panel of β-CoV broadly neutralizing antibodies to date

Association of benzodiazepines with SARS-CoV-2 positivity and clinical outcomes in three patient groups

The trajectory of B-cell immunity six months after mRNA vaccination

Long COVID symptoms in families a year after SARS-CoV-2 infection or household exposure

Cedars-Sinai scientists identify potential new therapy for COVID-19

New antimicrobial technology for air filters can kill bacteria, fungi and viruses in seconds

Causal links between severe COVID-19 and blood proteins identified via proteome-wide Mendelian randomization in new study

Study reveals differential blood glycoprotein profiles in symptomatic and asymptomatic COVID-19 patients

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News